Cold Plasma in Healthcare Market

Cold Plasma in Healthcare Market Overview

The global cold plasma in healthcare market size, valued at USD 2.57 billion in 2024, is projected to reach USD 2.98 billion in 2025 and USD 10.04 billion by 2035, representing a CAGR of 12.9% during the forecast period.

Cold Plasma in Healthcare Industry: In Summary

• The global cold plasma in healthcare market is experiencing significant growth, with a projected CAGR of 12.9% from 2025 to 2035. This expansion is primarily driven by the increasing adoption of cold plasma technology across various healthcare applications.
• Increasing government support for research and development, alongside exploration of new applications in dermatology (eczema, and acne), dentistry (disinfection, and teeth whitening), and oncology.
• Atmospheric pressure and low pressure cold plasma are the two main types of cold plasma pressure category which is widely used across healthcare industry for surface sterilization, and wound treatment.
• Atmospheric Pressure Cold Plasma (72% market share) due to its versatility, safety, and efficiency in equipment sterilization, wound healing, and surface modification. Low-pressure cold plasma is anticipated to grow at a higher CAGR, driven by its expanding use for surface sterilization and pathogen removal in hospitals to reduce hospital acquired infection.
• Wound healing (33% market share), widely accepted for promoting tissue regeneration and minimizing infection risk.
• In terms of regions, North America is currently holding 41% share of the market, and this region is expected to remain dominant in the future. This dominance is likely to be the result of increasing acceptance of cold plasma in healthcare industry for chronic wound treatment and surface sterilization to reduce the chance of hospital acquired infection.
• In terms of end user, hospitals will remain the primary users of cold plasma.
• Key players, such as Neoplas Med (Germany), and Apyx Medical (US) are focusing on developing highly efficient, safe, and portable cold plasma devices. Integration of AI, smart sensors, and real-time monitoring to enhance precision, improve outcomes, and automate processes.

Cold Plasma in Healthcare Market Introduction

Cold plasma, also refer as low-temperature plasma and non-thermal plasma signifies the fourth state of matter that differs from solid, liquids and gasses. In general, cold plasma is an ionized gas that contains a mixture of highly reactive free radicals, electrons and ions, while maintaining a neutral charge. Numerous methods has been implemented to generate plasma, such as dielectric barrier discharge (DBD), non-equilibrium atmospheric pressure plasma jets (N-APPJ), gliding arc discharge (GAD), corona glow discharges, inductively coupled plasmas, radio frequencies (RF), and microwave-induced plasma.

These key mechanism helps in generation of reactive oxygen and nitrogen species that has potential to eliminate microorganism and even cancerous cells. This unique characteristics make it suitable for wide healthcare applications, such as wound healing, sterilization of surgical equipment, and also used as cancer therapy. One of the driver that increases the demand of cold plasma for medical application is rising prevalence of conditions, such as chronic wounds, diabetic ulcers and hospital-acquired infections. Cold plasma therapy helps to target pathogens without causing damage to sensitive tissues.

Notably, several industrial players are increasing initiatives for innovations and expanding its application in healthcare. For instance, in June 2025, a latest Neoplas Argon Jet system, a cold plasma device developed through a German European scientific collaboration led by Leibniz Institute for Plasma Science and Technology and Neoplas Med (Germany) has been launched in Oman. This newly launched Neoplas Argon Jet system offers a non-invasive alternative treatment to treat infections. These innovations in cold plasma technologies and increasing demand reflect a long-term competitiveness in cold plasma in healthcare market.

Cold Plasma in Healthcare Market: Report Attributes

One of the key objectives of the cold plasma in healthcare market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.

The global cold plasma in healthcare market analysis also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of pressure, application area, end user, geographical regions, and leading players.

In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.

Recent Developments in Cold Plasma in Healthcare Market

Several recent developments in the field of cold plasma in healthcare industry have occurred, and we outlined some of these below.

• In February 2025, Royal Wound-X (US), division of Royal Biologics (US), announced a strategic partnership with Coldplasmatech (Germany) to revolutionize the advance wound care. Under this partnership Royal Wound-X (US) will utilize the latter company’s cold atmospheric plasma (CAP) technology that consist of CPT®cube (automated control device) and CPT®patch (a wound applicator) to treat complex wound.

Cold Plasma in Healthcare Market Segmentation Insights

The market report provides comprehensive information on cold plasma in healthcare industrial players who are currently active across various segments of the industry as mentioned in the table below.

Cold Plasma in Healthcare Market: Market Segmentation

Cold Plasma in Healthcare Market Share Insights

Market Share by Type of Pressure: Why is Atmospheric Pressure Cold Plasma Dominating the Market?

• This segment is sub-divided based on type of pressure into low-pressure cold plasma and atmospheric pressure cold plasma. According to the cold plasma in healthcare market forecast, the atmospheric pressure cold plasma segment is dominating the market by holding 72% of the market share. This can be attributed to the fact that atmospheric pressure provide optimal environment for cold plasma therapy. It is highly versatile, safe and efficient for performing equipment sterilization, wound healing, surface modification and many more medical treatments.
• While atmospheric pressure cold plasma segment holds a dominating position, low-pressure cold plasma segment is likely to grow at a higher CAGR during the forecast period. This lucrative growth is driven by the expanding usage of low pressure cold plasma for sterilization of surface and pathogen removal in hospitals to reduce the chances of hospital acquired infection.

Market Share by End User: Do Hospitals Segment Continue to Maintain Its Dominance in the Future?

• Based on the end user, the global market is segmented into hospitals, dental clinics, and research and academic institutions. Currently, the hospitals segment holds nearly 45% of the cold plasma in healthcare market share and dominance is likely to remain unchanged during the forecast period. This dominance is due to the high adoption of cold plasma technology for equipment sterilization, advanced wound care treatment and cancer treatment. Furthermore, the need for controlling hospital acquired infection has further underscored the demand for cold plasma technology in hospitals.
• It is worth mentioning that hospitals segment will continue to grow at a higher CAGR during the forecast period. Several factors, such as increasing usage of infection control technologies and expanding usage of cold plasma technology to treat chronic conditions are the key reasons for lucrative growth of this segment.

Cold Plasma in Healthcare Market: Report Deliverables

Cold Plasma in Healthcare Market Major Takeaways

The “Cold Plasma in Healthcare Market Report: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics, and future opportunities for cold plasma in healthcare industry players. The market research report lays emphasis on the cold plasma technologies that are being developed for healthcare industry. Key takeaways of the market report are briefly discussed below.

Cold Plasma in Healthcare Market Competitive Landscape: Is this Market Competitive?

The cold plasma industry is moderately competitive, featuring the presence of several small, mid-sized and large companies. Notably, the key players active in this industry, such as Europlasma (UK), Neoplas Med (Germany), and Apyx Medical (US) are increasing cold plasma technology innovations to enhance the efficiency, versatility, and applicability across wide healthcare sector. Some of the latest innovation by industrial players are listed below.

• Neoplas Med (Germany): This company has specialization in cold physical plasma for medical application, specifically wound healing. Currently, the Neoplas Med has launched plasmajet iKINPen®, the first plasmajet CE-marked as a class IIa medical device to treat chronic wounds and pathogen-induced skin disorders.
• Relyon Plasma (Germany): This company is well-known for cold plasma systems innovative plasma for wide range of medical applications. Some of the recent innovations includes, Plasmacell P300 (stand-alone system), Piezobrush PZ2/PZ2-i (surface activation), and Plasmatool.
• Apyx Medical (US): This company is highly known for its Helium Plasma platform technology products, Renuvion, and J-Plasma that are widely used in cosmetic and hospital surgical markets. The company has recently received USFDA clearance for its AYON Body Contouring System that utilizes cold plasma technology and radiofrequency to create controlled, cold plasma steam for body contouring.
• TOMI Environmental Solutions (US): Recently, this company has commercialized DARPA-pioneered iHP® (ionized Hydrogen Peroxide) technology, leveraging atmospheric cold plasma for disinfection and decontamination.

The accelerating pace of innovation by established players coupled with increasing awareness of cold plasma's benefits, such as its non-thermal, eco-friendly nature and efficacy against antibiotic-resistant strains, is fostering robust market growth and attracting further investment in research and development.

Personalize Your Report

Cold Plasma in Healthcare Market Challenges: What are the Challenges in the Market?

High Initial Investment for Cold Plasma Technology

Cold plasma has a broad scope in healthcare industry. However, there are some challenges that needs to be addressed. One of the potential barrier is high initial investment to install cold plasma equipment and technology. This substantial capital expenditure can be prohibitive for the market players.

Technology Complexity and Regulatory Hurdles

It is important to highlight here that the implementation of cold plasma technology often requires specialized knowledge and skills. Therefore, the lack of specialized persons to operate cold plasma technology may hinder the market progress. Moreover, integrating these advanced technologies into established clinical workflows or existing manufacturing lines can be cumbersome, resource-intensive, and time-consuming.

Additionally, competition from alternate technologies remains a significant challenge for the market player. While cold plasma offers distinct advantages, established traditional methods, such as heat sterilization, chemical disinfection, UV sterilization, ethylene oxide, gamma irradiation, and mechanical surface preparation will continue to present competition.

Regional Brief: Which Region Offer a Strong Base for Cold Plasma in Healthcare Market Expansion?

The cold plasma in healthcare market is poised for continued robust growth, driven by a combination of untapped geographical potential, a strong regulatory push towards sustainability, and ongoing technological advancements.

Cold Plasma in Health Market Report Coverage

The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders in the cold plasma industry, across different geographies. Amongst other elements, the market report includes:

• An Infographic Executive Summary
• Competitive Landscape
• Company Competitiveness Analysis
• Company Profiles
• SWOT Analysis
• Market Impact Analysis
• Market Opportunity Analysis
• Key Winning Strategies
• Value Chain Analysis

Glossary

• Plasma: It refers to the fourth state of matter, an ionized gas containing a mixture of free radicals, ions, electrons, and neutral particles. Notably, plasma has a net neutral charge and can exist in either its ground or excited states.
• Atmospheric Pressure Cold Plasma: It refers to the partially ionized gas which is generated at atmospheric pressure. It contains reactive oxygen and nitrogen species (RONS) that are responsible for the biological and chemical effects.
• Chronic Wounds: These are a type of wounds that does not heal with natural progress mechanism and typically takes months to recover. Chronic wounds cause prolonged inflammation and can also be occurred due to poor blood circulation, diabetes, or a weakened immune system.

From the Author’s Desk

Author’s View on Cold Plasma in Healthcare Market

The cold plasma in healthcare market represents a compelling opportunity, fundamentally driven by its unique technological advantages and its strong alignment with critical global megatrends, such as sustainability, health and safety, and advanced manufacturing. Further, the current market landscape has been strengthened by the growing partnerships and collaborations between industrial players for technological innovations. While regulatory hurdles remain a considerable barrier for market growth, several trends, such as transformative technology, and eco-friendly cold plasma solutions can reshape the industrial growth in the future.

Frequently Asked Questions